State Of Wyoming Zentalis Pharmaceuticals, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$66.92 - $84.79 $5,554 - $7,037	-83 Closed	0 $0
Q3 2021 Feb 11, 2022	SELL	$46.83 - $73.5 $27,957 - $43,879	-597 Reduced 87.79%	83 $6,000
Q2 2021 Feb 11, 2022	BUY	$37.41 - $62.25 $14,477 - $24,090	387 Added 132.08%	680 $36,000
Q1 2021 Feb 08, 2022	BUY	$35.69 - $52.72 $10,457 - $15,446	293 New	293 $13,000

142

76.3M

68.2K

2.3K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $233M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.